Notably, 5% to 10% of children with DS under four years of age are diagnosed with the preleukemic state of transient myeloproliferative disorder (TMD), which is invariably driven by GATA1 mutations generating a protein with a truncated N-terminus (GATA1s). The gene discussed is GATA1; the disease is transient myeloproliferative syndrome.